The role of magnetic resonance imaging in patients with palpable breast abnormalities and negative mammographic and sonographic findings.
Ceren YalnizDanea CampbellCarisa Le-PetrossKyungmin ShinTherese B BeversKenneth R HessGary J WhitmanPublished in: The breast journal (2020)
Breast MRI to evaluate palpable abnormalities after negative mammography and ultrasound results in a low yield for malignancy. The majority of patients (67.7%) had negative MRI examinations, and there were no malignancies detected. Our findings lead us to believe that there are no data to encourage the use of MRI in patients with palpable abnormalities and negative mammographic and/or ultrasound studies.
Keyphrases
- contrast enhanced
- magnetic resonance imaging
- end stage renal disease
- diffusion weighted imaging
- ejection fraction
- computed tomography
- newly diagnosed
- chronic kidney disease
- magnetic resonance
- prognostic factors
- electronic health record
- big data
- patient reported outcomes
- ultrasound guided
- optical coherence tomography